创新医疗
(002173)
| 流通市值：39.20亿 | | | 总市值：41.61亿 |
| 流通股本：4.16亿 | | | 总股本：4.41亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 610,403,522.18 | 408,040,808.16 | 201,344,535.99 | 805,585,526.56 |
| 营业收入 | 610,403,522.18 | 408,040,808.16 | 201,344,535.99 | 805,585,526.56 |
| 二、营业总成本 | 636,374,560.84 | 417,087,062.79 | 202,244,492.52 | 828,477,736.82 |
| 营业成本 | 549,235,540.15 | 359,936,326.97 | 176,622,830.79 | 713,376,688.89 |
| 税金及附加 | 8,406,806.62 | 5,730,453.92 | 3,238,757.4 | 9,775,931.67 |
| 销售费用 | 7,847,677.8 | 4,135,533.55 | 1,962,464.82 | 10,296,941.07 |
| 管理费用 | 76,443,328.95 | 51,057,964.97 | 22,771,232.23 | 107,726,934.05 |
| 财务费用 | -5,558,792.68 | -3,773,216.62 | -2,350,792.72 | -12,698,758.86 |
| 其中:利息费用 | 2,049,213.27 | 1,113,519.73 | 659,072.06 | 3,647,536.92 |
| 其中:利息收入 | 9,309,805.45 | 6,080,949.39 | 3,538,058.68 | 17,416,938.71 |
| 加:公允价值变动收益 | 2,617,698.8 | 278,672.9 | 199,882.7 | 78,554.1 |
| 加:投资收益 | -1,902,403.77 | -1,117,134.37 | -327,699.86 | -1,916,659.76 |
| 资产处置收益 | -625,408.72 | -625,408.72 | - | 1,059,985.19 |
| 资产减值损失(新) | -88,310.69 | -88,310.69 | - | -624,506.01 |
| 信用减值损失(新) | -3,964,805.78 | -4,784,215.17 | -1,376,230.41 | -2,711,985.09 |
| 其他收益 | 1,779,292.03 | 768,424.52 | 291,678.89 | 1,367,164.68 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -28,154,976.79 | -14,614,226.16 | -2,112,325.21 | -25,639,657.15 |
| 加:营业外收入 | 5,239,610.2 | 5,103,278.07 | 77,986.69 | 5,312,455.62 |
| 减:营业外支出 | 6,091,138.49 | 5,543,942.29 | 1,304,664.97 | 14,637,639.43 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -29,006,505.08 | -15,054,890.38 | -3,339,003.49 | -34,964,840.96 |
| 减:所得税费用 | -1,309,645.32 | 830,260.35 | -359,443.5 | -676,547.26 |
| 六、净利润 | -27,696,859.76 | -15,885,150.73 | -2,979,559.99 | -34,288,293.7 |
| 持续经营净利润 | -27,696,859.76 | -15,885,150.73 | -2,979,559.99 | -34,288,293.7 |
| 归属于母公司股东的净利润 | -27,844,147.16 | -16,029,593.18 | -2,977,863.39 | -34,287,743.35 |
| 少数股东损益 | 147,287.4 | 144,442.45 | -1,696.6 | -550.35 |
| (一)基本每股收益 | -0.06 | -0.04 | -0.01 | -0.08 |
| (二)稀释每股收益 | -0.06 | -0.04 | -0.01 | -0.08 |
| 九、综合收益总额 | -27,696,859.76 | -15,885,150.73 | -2,979,559.99 | -34,288,293.7 |
| 归属于母公司股东的综合收益总额 | -27,844,147.16 | -16,029,593.18 | -2,977,863.39 | -34,287,743.35 |
| 归属于少数股东的综合收益总额 | 147,287.4 | 144,442.45 | -1,696.6 | -550.35 |
| 公告日期 | 2024-10-25 | 2024-08-10 | 2024-04-27 | 2024-04-13 |
| 审计意见(境内) | | | | 标准无保留意见 |